These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34604593)

  • 41. Control of an outbreak of diarrhoea in a vascular surgery unit caused by a high-level clindamycin-resistant Clostridium difficile PCR ribotype 106.
    Ratnayake L; McEwen J; Henderson N; Nathwani D; Phillips G; Brown D; Coia J
    J Hosp Infect; 2011 Nov; 79(3):242-7. PubMed ID: 21864938
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multicenter study of Clostridium difficile infection rates from 2000 to 2006.
    Dubberke ER; Butler AM; Yokoe DS; Mayer J; Hota B; Mangino JE; Khan YM; Popovich KJ; Fraser VJ
    Infect Control Hosp Epidemiol; 2010 Oct; 31(10):1030-7. PubMed ID: 20695799
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Environmental interventions to control Clostridium difficile.
    Loo VG
    Infect Dis Clin North Am; 2015 Mar; 29(1):83-91. PubMed ID: 25573675
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Five years experience of Clostridium difficile infection in children at a UK tertiary hospital: proposed criteria for diagnosis and management.
    Pai S; Aliyu SH; Enoch DA; Karas JA
    PLoS One; 2012; 7(12):e51728. PubMed ID: 23300561
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of a training program on the surveillance of Clostridioides difficile infection.
    Sopena N; Freixas N; Bella F; Pérez J; Hornero A; Limon E; Gudiol F; Pujol M;
    Epidemiol Infect; 2019 Jan; 147():e231. PubMed ID: 31364565
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nosocomial or hospital-acquired infections: an overview.
    McFee RB
    Dis Mon; 2009 Jul; 55(7):422-38. PubMed ID: 19540995
    [No Abstract]   [Full Text] [Related]  

  • 47. National European guidelines for the prevention of Clostridium difficile infection: a systematic qualitative review.
    Martin M; Zingg W; Knoll E; Wilson C; Dettenkofer M;
    J Hosp Infect; 2014 Aug; 87(4):212-9. PubMed ID: 24957805
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of the National Healthcare Safety Network standardized infection ratio risk adjustment for healthcare-facility-onset
    Polage CR; Quan KA; Madey K; Myers FE; Wightman DA; Krishna S; Grein JD; Gibbs L; Yokoe D; Mabalot SC; Chinn R; Hallmark A; Rubin Z; Fontenot M; Cohen S; Birnbaum D; Huang SS; Torriani FJ
    Infect Control Hosp Epidemiol; 2020 Apr; 41(4):404-410. PubMed ID: 32052726
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantitative Results of a National Intervention to Prevent Clostridioides difficile Infection: A Pre-Post Observational Study.
    Dubberke ER; Rohde JM; Saint S; Jones K; Snyder A; Rolle AJ; Chopra V
    Ann Intern Med; 2019 Oct; 171(7_Suppl):S52-S58. PubMed ID: 31569233
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Holding back the tide.
    Drabu Y
    Nurs Manag (Harrow); 2008 Jun; 15(3):14-7. PubMed ID: 18575205
    [No Abstract]   [Full Text] [Related]  

  • 51. Community-Associated Clostridioides difficile Infection in Children: A Review of Recent Literature.
    Adams DJ; Barone JB; Nylund CM
    J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S22-S26. PubMed ID: 34791398
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Three-year epidemiological analysis of Clostridioides difficile infection and the value of hospital-infection control measures in a tertiary-care teaching hospital in Japan using PCR-based open-reading frame typing.
    Nakaie K; Yamada K; Kuwabara G; Imoto W; Yamairi K; Shibata W; Oshima K; Niki M; Sakurai N; Nonose Y; Okada Y; Fujita A; Kaneko Y; Kakeya H
    J Infect Chemother; 2021 Feb; 27(2):179-184. PubMed ID: 32950394
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The association of hospital prevention processes and patient risk factors with the risk of Clostridium difficile infection: a population-based cohort study.
    Daneman N; Guttmann A; Wang X; Ma X; Gibson D; Stukel TA
    BMJ Qual Saf; 2015 Jul; 24(7):435-43. PubMed ID: 25911052
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Infection prevention and control practices related to Clostridium difficile infection in Canadian acute and long-term care institutions.
    Wilkinson K; Gravel D; Taylor G; McGeer A; Simor A; Suh K; Moore D; Kelly S; Boyd D; Mulvey M; Mounchili A; Miller M;
    Am J Infect Control; 2011 Apr; 39(3):177-82. PubMed ID: 21458680
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proposed checklist of hospital interventions to decrease the incidence of healthcare-associated Clostridium difficile infection.
    Abbett SK; Yokoe DS; Lipsitz SR; Bader AM; Berry WR; Tamplin EM; Gawande AA
    Infect Control Hosp Epidemiol; 2009 Nov; 30(11):1062-9. PubMed ID: 19751156
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Multifaceted Approach to the Prevention of Clostridioides (Clostridium) Difficile.
    Pate K; Reece J; Smyre A
    Clin Nurse Spec; 2019; 33(2):75-81. PubMed ID: 30730451
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discordant
    Lenggenhager L; Zanella MC; Poncet A; Kaiser L; Schrenzel J
    BMJ Open; 2020 Sep; 10(9):e036342. PubMed ID: 32928850
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Multicenter Evaluation of Probiotic Use for the Primary Prevention of Clostridioides difficile Infection.
    Heil EL; Harris AD; Brown C; Seung H; Thom KA; von Rosenvinge E; Sorongon S; Pineles L; Goodman KE; Leekha S
    Clin Infect Dis; 2021 Oct; 73(8):1330-1337. PubMed ID: 33972996
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Environmental services impact on healthcare-associated Clostridium difficile reduction.
    Daniels T; Earlywine M; Breeding V
    Am J Infect Control; 2019 Apr; 47(4):400-405.e1. PubMed ID: 30554878
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Substantial reduction of healthcare facility-onset Clostridioides difficile infection (HO-CDI) rates after conversion of a hospital for exclusive treatment of COVID-19 patients.
    Ochoa-Hein E; Rajme-López S; Rodríguez-Aldama JC; Huertas-Jiménez MA; Chávez-Ríos AR; de Paz-García R; Haro-Osnaya A; González-Colín KK; González-González R; González-Lara MF; Ponce-de-León A; Galindo-Fraga A
    Am J Infect Control; 2021 Jul; 49(7):966-968. PubMed ID: 33352250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.